Skip to main content

Advertisement

Log in

Expression vector cassette engineering for recombinant therapeutic production in mammalian cell systems

  • Mini-Review
  • Published:
Applied Microbiology and Biotechnology Aims and scope Submit manuscript

Abstract

Human tissue plasminogen activator was the first recombinant therapy protein that successfully produced in Chinese hamster ovary cells in 1986 and approved for clinical use. Since then, more and more therapeutic proteins are being manufactured in mammalian cells, and the technologies for recombinant protein production in this expression system have developed rapidly, with the optimization of both upstream and downstream processes. One of the most promising strategies is expression vector cassette optimization based on the expression vector cassette. In this review paper, these approaches and developments are summarized, and the future strategy on the utilizing of expression cassettes for the production of recombinant therapeutic proteins in mammalian cells is discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

Download references

Funding

This work was supported by the Grants from Basic Research Foundation of Key Scientific Research of Universities in Henan Province (No. 20zx013), Major Science and Technology projects of Henan Province (No. 191110311500), the Key Scientific Research Projects in Universities of Henan Province (No. 19A350008).

Author information

Authors and Affiliations

Authors

Contributions

Xiao Guo reviewed and wrote the manuscript. Tian-Yun Wang designed, analyzed, and co-wrote the manuscript.

Corresponding author

Correspondence to Tian-Yun Wang.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Human and animal rights and informed consent

This article does not contain any studies with human participants or animals performed by any of the authors.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Key points

Expression vector cassette engineering in mammalian cell systems is reviewed.

Vector engineering can improve the expression of recombinant protein.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, TY., Guo, X. Expression vector cassette engineering for recombinant therapeutic production in mammalian cell systems. Appl Microbiol Biotechnol 104, 5673–5688 (2020). https://doi.org/10.1007/s00253-020-10640-w

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00253-020-10640-w

Keywords

Navigation